L'Oreal shares slide after China dents quarterly sales
Shares have fallen more than a fifth this year
Analysts say results worse than expected
Competitor companies also face headwinds
Recasts throughout, adds chart, peer company reporting dates, analyst comment
By Dominique Patton
PARIS, Oct 23 (Reuters) -L'Oreal's OREP.PA shares on Wednesday extended a deep sell-off after the cosmetics giant reported quarterly sales below expectations, citing reduced beauty products demand in China and slower growth for its dermatological division.
Shares were down 3.7% at 0844 GMT, hovering around their lowest levels since January 2023. They have plunged more than a fifth this year, including 20% since June.
Across a broad range of companies, China's economic weakness has curbed customer buying and the luxury sector, reliant on discretionary spending, has been hard hit.
After the market close on Tuesday, L'Oreal, which sells luxury labels including Lancome and Kiehls and mass market products such as Maybelline mascara, posted a 3.4% rise in sales for the three months to the end of September to 10.28 billion euros ($11.10 billion). That was below a Visible Alpha consensus of 6% cited by Jefferies.
Investors were nervous ahead of the results, but the numbers were worse than expected, said Barclays analysts.
"L'Oréal has missed three out of the last four quarters, with China consistently worse than we feared," they said in a note.
The China market deteriorated, with luxury beauty products in the "negative mid-teens," and as an expected improvement in travel retail did not materialise, Chief Executive Nicolas Hieronimus told analysts late on Tuesday.
"We expect a tough Q4 2024 and Q1 2025 ahead," wrote JP Morgan in a note on L'Oreal, while Deutsche Bank analysts reiterated their "sell" rating on L'Oreal.
BROADER ISSUES
Smaller, U.S.-based rival Coty COTY.N last week warned its first quarter sales, publishing on Nov. 6, would be below forecast following tight order and inventory management by retailers in markets such as Australia and China and the United States.
Developed markets at L'Oreal "grew robustly", however, with strength in U.S. fragrance demand offsetting weakness in the U.S. make-up market, Barclays said.
Although the company's problems are mostly a result of difficult market conditions, Barclays said comment from L'Oreal management that more innovation was needed to appeal to younger customers, was "tacit acknowledgement that execution could tighten up".
Elswhere in the sector, Nivea-maker Beiersdorf reports third quarter results on Thursday, and Estee Lauder EL.N reports its first quarter for 2025 on Oct. 31.
On Wednesday, Beiersdorf BEIG.DE shares also fell 1.5% at market open, before paring losses.
($1 = 0.9263 euros)
Cosmetics companies' shares have fallen this year https://tmsnrt.rs/4hdNc51
Reporting by Dominique Patton;
Editing by Sudip Kar-Gupta and Barbara Lewis
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
